ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,894Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 807

$666K Total Retail Price of All Prescriptions

Rank: 45 out of 807

756 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 756 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 756 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 11,166 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 656 592 1 1
LEVOTHYROXINE SODIUM 569 513 2 3
OMEPRAZOLE 526 447 3 4
AMLODIPINE BESYLATE 425 384 4 5
LISINOPRIL 413 389 5 2
ATENOLOL 356 333 6 7
HYDROCODONE-ACETAMINOPHEN 352 280 S3 7 15
METFORMIN HCL 333 271 8 12
ALENDRONATE SODIUM 319 314 9 20
METOPROLOL TARTRATE 319 288 9 8
WARFARIN SODIUM 240 227 11 10
FUROSEMIDE 228 210 12 6
ATORVASTATIN CALCIUM 219 172 13 11
GABAPENTIN 211 175 14 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 202 186 15 28
HYDROCHLOROTHIAZIDE 198 177 16 9
FLUTICASONE PROPIONATE 195 182 17 30
PRAVASTATIN SODIUM 192 177 18 21
CARVEDILOL 185 169 19 35
POTASSIUM CHLORIDE 184 176 20 18
TRIAMTERENE-HCTZ 178 177 21 29
CITALOPRAM HBR 155 126 22 17
HYDRALAZINE HCL 143 138 23 62
GLIMEPIRIDE 141 111 24 51
METOPROLOL SUCCINATE 141 139 24 13
VITAMIN D2 138 138 26 133
ZOLPIDEM TARTRATE 136 120 27 23
TORSEMIDE 133 108 28 106
POLYETHYLENE GLYCOL 3350 127 102 29 40
PREDNISONE 102 86 30 24
TRAMADOL HCL 79 50 31 19
DIGOXIN 79 73 31 41
TERAZOSIN HCL 76 69 33 78
LOSARTAN POTASSIUM 73 71 34 14
MIRTAZAPINE 71 52 35 38
PROAIR HFA 68 44 36 43
ADVAIR DISKUS 67 46 37 33
LABETALOL HCL 65 65 38 178
RANITIDINE HCL 65 64 38 34
ALLOPURINOL 62 58 40 26
KLOR-CON 10 61 61 41 81
JANTOVEN 60 60 42 37
SERTRALINE HCL 58 53 43 22
LANTUS SOLOSTAR 58 52 43 42
AZITHROMYCIN 58 49 43 57
CLOPIDOGREL 57 51 46 47
OXYBUTYNIN CHLORIDE ER 55 37 47 118
CIPROFLOXACIN HCL 53 48 48 72
MORPHINE SULFATE ER 53 42 S2 48 107
COMBIVENT 52 19 50 162
ESCITALOPRAM OXALATE 50 41 51 115
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.